Intel waiting for key update before going Vista

Won't leap until SP1 arrives


If it's not good enough for Intel, is it good enough for you? We're talking Microsoft's Windows Vista, which the chip giant's CEO, Paul Otellini, this week indicated has not won the backing of his technology experts.

"I know of no organisation doing an upgrade before [Service Pack 1]," Paul Otellini told attendees of the Bank of America Technology Conference held in San Francisco this week, according to a ZDnet blog. "Intel isn't upgrading either."

Vista is "closer to the Mac than we've been on the Windows side for a long time", Otellini added. Otellini has praised the Apple operating system before, and is believed to have played a key role in persuading the Mac maker to adopt his company's processor technology.

A Microsoft's operating system's first Service Pack - what MS calls major updates - usually patches an array of glitches discovered in the initial version of the product.

While that approach may persuade big business to delay upgrading, consumers are more likely to be grabbed by the new OS' slick visuals. But even in this segment of the market, demand will take time to build up as folk buy new PCs with Vista pre-installed and get a chance to play with it, Otellini indicated.

Similar topics

Broader topics


Other stories you might like

  • Google sours on legacy G Suite freeloaders, demands fee or flee

    Free incarnation of online app package, which became Workplace, is going away

    Google has served eviction notices to its legacy G Suite squatters: the free service will no longer be available in four months and existing users can either pay for a Google Workspace subscription or export their data and take their not particularly valuable businesses elsewhere.

    "If you have the G Suite legacy free edition, you need to upgrade to a paid Google Workspace subscription to keep your services," the company said in a recently revised support document. "The G Suite legacy free edition will no longer be available starting May 1, 2022."

    Continue reading
  • SpaceX Starlink sat streaks now present in nearly a fifth of all astronomical images snapped by Caltech telescope

    Annoying, maybe – but totally ruining this science, maybe not

    SpaceX’s Starlink satellites appear in about a fifth of all images snapped by the Zwicky Transient Facility (ZTF), a camera attached to the Samuel Oschin Telescope in California, which is used by astronomers to study supernovae, gamma ray bursts, asteroids, and suchlike.

    A study led by Przemek Mróz, a former postdoctoral scholar at the California Institute of Technology (Caltech) and now a researcher at the University of Warsaw in Poland, analysed the current and future effects of Starlink satellites on the ZTF. The telescope and camera are housed at the Palomar Observatory, which is operated by Caltech.

    The team of astronomers found 5,301 streaks leftover from the moving satellites in images taken by the instrument between November 2019 and September 2021, according to their paper on the subject, published in the Astrophysical Journal Letters this week.

    Continue reading
  • AI tool finds hundreds of genes related to human motor neuron disease

    Breakthrough could lead to development of drugs to target illness

    A machine-learning algorithm has helped scientists find 690 human genes associated with a higher risk of developing motor neuron disease, according to research published in Cell this week.

    Neuronal cells in the central nervous system and brain break down and die in people with motor neuron disease, like amyotrophic lateral sclerosis (ALS) more commonly known as Lou Gehrig's disease, named after the baseball player who developed it. They lose control over their bodies, and as the disease progresses patients become completely paralyzed. There is currently no verified cure for ALS.

    Motor neuron disease typically affects people in old age and its causes are unknown. Johnathan Cooper-Knock, a clinical lecturer at the University of Sheffield in England and leader of Project MinE, an ambitious effort to perform whole genome sequencing of ALS, believes that understanding how genes affect cellular function could help scientists develop new drugs to treat the disease.

    Continue reading

Biting the hand that feeds IT © 1998–2022